Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516440 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Analytical Tool - Prostate Cancer: A Therapeutic' returned 271 results - Page 1 of 14

  Sort by   
  Sorted by Rank Top-Bottom

Analytical Tool - Lung Cancer  
Bioseeker, Feb 2012
Analytical Tool - Lung Cancer Analytical Tool - Lung Cancer is a premium combo product of "Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market" and "Lung Cancer


Triple Analysis: Breast Cancer, Lung Cancer and Cancer Vaccines  
Bioseeker, July 2011, Pages: 2895
: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part III: Cancer Vaccines The cancer vaccine report part comprises defined and up to date development strategies


Triple Analysis: Colorectal Cancer, Lung Cancer and Cancer Vaccines  
Bioseeker, July 2011, Pages: 3038
cancer. This part is based on the following publication: A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market Part II: Lung Cancer The lung cancer


Triple Analysis: Breast Cancer, Colorectal Cancer and Cancer Vaccines  
Bioseeker, March 2011, Pages: 2628
publication: A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market Part III: Cancer Vaccines The cancer vaccine report part comprises defined and up to


Triple Analysis: Breast Cancer, Colorectal Cancer and Lung Cancer  
Bioseeker, July 2011, Pages: 3292
drug target strategies, and assesses them in eight different compound strategies in colorectal cancer. This part is based on the following publication: A Decision Support Tool for Optimizing The


Triple Analysis: Lung Cancer, Pancreatic Cancer and Cancer Vaccines  
Bioseeker, March 2012, Pages: 3085
cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Pancreatic Cancer The pancreatic cancer report


Triple Analysis: Breast Cancer, Pancreatic Cancer and Cancer Vaccines  
Bioseeker, March 2012, Pages: 2675
strategies, and assesses them in 42 different cancer indications. This part is based on the following publication: Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline The


Triple Analysis: Breast Cancer, Lung Cancer and Pancreatic Cancer  
Bioseeker, March 2012, Pages: 3339
strategies, and assesses them in eight different compound strategies and and three subindications of lung cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for


Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market  
Bioseeker, July 2011, Pages: 1323
Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market This report comprises defined and up to date development strategies for 416 lung cancer drugs within the


Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Cancer Vaccines  
Bioseeker, March 2012, Pages: 2818
colorectal cancer. This part is based on the following publication: A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market Part II: Pancreatic Cancer


Triple Analysis: Colorectal Cancer, Lung Cancer and Pancreatic Cancer  
Bioseeker, March 2012, Pages: 3482
on the following publication: A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market Part II: Lung Cancer The lung cancer report part comprises


Triple Analysis: Breast Cancer, Colorectal Cancer and Pancreatic Cancer  
Bioseeker, March 2012, Pages: 3072
, organized into 205 drug target strategies, and assesses them in eight different compound strategies in colorectal cancer. This part is based on the following publication: A Decision Support Tool for


Triple Analysis: Lung Cancer, Cancer Vaccines and Antibodies  
Bioseeker, Sep 2011, Pages: 3926
and three subindications of lung cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Cancer


Triple Analysis: Breast Cancer, Cancer Vaccines and Antibodies  
Bioseeker, Sep 2011, Pages: 3516
publication: Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development


Triple Analysis: Lung Cancer, Apoptosis and Cancer Vaccines  
Bioseeker, Dec 2011, Pages: 3599
cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Apoptosis The apoptotic cancer drug report part


Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines  
Bioseeker, Jan 2012, Pages: 3686
cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Angiogenesis The angiogenesis affecting cancer


Triple Analysis: Lung Cancer, Cancer Vaccines and Peptides  
Bioseeker, Nov 2011, Pages: 2888
and three subindications of lung cancer. This part is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Cancer


Triple Analysis: Breast Cancer, Apoptosis and Cancer Vaccines  
Bioseeker, Dec 2011, Pages: 3189
different cancer indications. This part is based on the following publication: Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline The report is written for you to


Triple Analysis: Breast Cancer, Angiogenesis and Cancer Vaccines  
Bioseeker, Jan 2012, Pages: 3276
strategies, and assesses them in 42 different cancer indications. This part is based on the following publication: Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline The


Triple Analysis: Breast Cancer, Cancer Vaccines and Peptides  
Bioseeker, Nov 2011, Pages: 2478
: Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline Part III: Peptides The cancer peptide drug report part comprises defined and up to date development strategies for 152 peptide


Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds